Screening as a Strategic Challenge
With the launch of the national lung cancer screening program in 2026, hospitals and screening centers across Germany are facing a complex challenge: implementing a program with high demands on IT infrastructure, data management, interoperability, and regulatory compliance.
Beyond clinical quality, one factor will be critical to success: how efficiently screening workflows can be integrated into existing systems and operational processes.
mint Lesion provides a comprehensive platform that connects all key components of lung cancer screening:
The result is a connected, data-driven ecosystem that supports the entire screening workflow from end to end.
One of the greatest challenges in lung cancer screening is cross-site collaboration. By definition, screening programs require interconnected workflows: primary and secondary reading centers, heterogeneous IT systems, and external registries must communicate seamlessly.
In practice, however, limited interoperability often results in workflow disruptions, inefficient processes, and potential data loss. This is exactly where mint Lesion comes in.
The platform enables seamless integration into existing system environments and ensures that data is available exactly where it is needed:
This creates a continuous data flow across institutional boundaries.
The result: no data silos, but connected and efficient workflows that form the foundation of a functional screening network.
Lung cancer screening is not an isolated use case, but a long-term program connecting multiple institutions and levels of care. As a result, scalability and flexibility are essential requirements for the underlying IT infrastructure.
mint Lesion was specifically designed to support these requirements and can be implemented both in individual institutions and across complex screening networks.
The platform enables:
Whether based on centralized or decentralized architectures, mint Lesion adapts to existing infrastructures and scales alongside the program’s requirements.
This creates a future-ready infrastructure that supports not only the launch of lung cancer screening programs, but also their long-term evolution—making the platform suitable for both individual hospitals and large healthcare networks.
Artificial intelligence has enormous potential in lung cancer screening, but its use must align with both regulatory requirements and clinical standards. For hospitals, this means AI solutions must not only be powerful, but also secure, transparent, and fully integrable into clinical workflows.
mint Lesion enables the controlled and structured integration of AI applications into existing clinical environments.
The platform supports:
AI is therefore not implemented as an isolated tool, but as an integrated component of the infrastructure—always under the control of the radiologist.
The result is a scalable and regulation-compliant AI deployment that supports both workflow efficiency and clinical safety.
One of the core goals of lung cancer screening is not only early detection, but also the systematic use of data for quality assurance and continuous improvement of patient care.
This requires structured, standardized, and secure data collection.
mint Lesion supports this approach through:
Through consistent data structuring, information becomes more than documentation—it becomes actionable.
Every report can serve as a foundation for reliable analytics, scientific insights, and the continuous optimization of screening programs.
Lung cancer screening places high demands on organization, IT infrastructure, and data management.
mint Lesion provides a scalable, interoperable, and regulation-compliant platform that helps hospitals implement screening programs efficiently and operate them successfully over the long term.
If you would like to learn more, schedule a meeting with one of our experts.
Want to dive deeper? Read our latest article on how mint Lesion supports radiologists in clinical practice.
